dOCRL maintains immune cell quiescence by regulating endosomal traffic

Area of Science:

• Cell Biology
• Immunology
• Genetics

Background:

• Lowe Syndrome is a genetic disorder affecting eyes, kidneys, and the nervous system.
• It stems from mutations in the phosphatidylinositol-5-phosphatase OCRL gene.
• OCRL's precise role in disease pathology remains unclear, despite its known functions in cellular trafficking.

Purpose of the Study:

• To investigate the cellular functions of OCRL in the context of Lowe Syndrome.
• To determine how OCRL mutations impact innate immune cells.

Main Methods:

• Utilized Drosophila melanogaster as a model organism.
• Analyzed cell-autonomous activation of hemocytes (macrophage-like cells) in docrl mutant flies.
• Investigated endocytic and endolysosomal trafficking pathways, including Rab11 and Rab7.
• Assessed immune signaling pathways (Toll, Jun kinase, STAT) and Spätzle secretion.

Main Results:

• Mutation of Drosophila OCRL (docrl) leads to cell-autonomous activation of hemocytes.
• docrl mutant hemocytes exhibit reduced Rab11-dependent recycling and increased Rab7-dependent late endosome traffic.
• Loss of docrl amplifies immune signaling pathways and causes mis-sorting and excessive secretion of the Toll ligand Spätzle.
• This immune cell activation is sensitive to Rab11 function.

Conclusions:

• OCRL-dependent endosomal trafficking is crucial for maintaining hemocyte quiescence.
• Disruption of endosomal traffic by docrl mutations leads to immune cell activation.
• Endosomal misregulation of signaling pathways may contribute to Lowe Syndrome symptoms.